Saturday 17 October 2026 Export BACK’s income statement to Excel — free account

IMAC Holdings, Inc.

IMAC Holdings, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $72,100.00, down 99.6% from fiscal 2022. In the quarter to September 2025, revenue grew 34.2%, EPS grew 16.7% and free cash flow fell 30.9%, each against the same quarter a year earlier.

0.00 0.00 NaN

Follow BACK

Alert me

Market cap: $150.0K
P/E: 0.0×
Fwd P/E: −0.6×
Dividend yield: —
F-score: n/a
Altman Z: −73.66
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 57.46%

Capital & Financial Ratios $m

Market Cap 0.15

Revenue 0.08

Net Income (12.45)

Free Cash Flow (4.90)

Net Debt (0.05)

Current Ratio 0.02

Debt/Equity 0.00

P/E ratio 0.00

Fwd P/E (0.63)

P/S ratio 0.00

P/B ratio 0.00

Past 5Y EPS Growth —

This Y EPS Growth 70.13%

Next Y EPS Growth (37.55%)

Next Y revenue growth (52.43%)

Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

EV/Sales against its own 10 years 44.62%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack

special payouts not included in total or ratios

Assets vs Liabilities $m

	2022	2023	2024	Q'25
Cash	1	0	1	0
Receivables	3	—	0	—
Inventory	—	—	—	—
Other	0	—	—	—
	11	1	1	0

	2022	2023	2024	Q'25
Payables	1	0	3	5
ST’ Debt	—	—	—	—
Other	0	—	—	—
	6	2	7	13

Compound Annual Growth %

	10y	5y	3y
Sales	—	(59.60%)	(82.22%)
Cash Flow	—	0.00%	0.00%
Earnings	—	0.00%	0.00%
Book Value	—	0.00%	0.00%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	0	—	0	—	—
’24	2	1	2	0	0
’22	4	5	4	3	16
’21	3	3	3	4	14
’20	3	3	3	3	13
’19	3	4	4	4	15
’18	0	1	3	3	7

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(1)	(1)	(1)	—	—
’24	0	(1)	(1)	(1)	(3)
’23	(1)	0	(1)	0	(3)
’22	(3)	(3)	(2)	(2)	(10)
’21	(2)	(3)	(1)	(2)	(8)
’20	(1)	(2)	(1)	(2)	(6)
’19	(1)	(1)	(1)	(1)	(4)

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	(1)	(1)	(1)	—	—
’24	0	(1)	(1)	(1)	(3)
’23	(1)	1	(1)	0	(2)
’22	(3)	(3)	(2)	(2)	(11)
’21	(2)	(3)	(2)	(2)	(8)
’20	(1)	(2)	(1)	(2)	(6)
’19	(1)	(1)	(1)	(2)	(5)

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	(1.08)	(0.89)	(1.15)	—	—
’24	—	(1.72)	(1.38)	(3.08)	(5.76)
’23	(3.30)	(1.20)	(2.63)	(1.25)	(8.47)
’22	(3.60)	(2.10)	(6.91)	(6.91)	(19.52)
’21	(4.50)	(2.40)	(3.43)	(2.60)	(14.04)
’20	(5.41)	(6.01)	(3.60)	1.20	(13.51)
’19	(8.11)	(6.31)	(5.71)	(4.80)	(25.22)

Fiscal quarters ending in the months shown.

value withheld pending a data check

Group	Line	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025e
Price, $
Price, $	Low	—	—	—	—	38.40	12.60	31.50	5.40	1.22	0.98	Analyst estimates 2025–2027 Powerpack
	High	—	—	—	—	216.15	148.50	82.50	44.70	12.15	7.75
People
People	Employees	—	—	95	124	132	139	177	85	4	15
	Revenue/emp, $m	—	0.00	0.01	0.05	0.11	0.09	0.08	0.19	0.00	0.00
Income, $m
Income, $m	Revenue	—	0	1	7	15	13	14	16	—	0
	Gross margin, %	—	(1,152.67)	100.00	100.00	100.00	100.00	100.00	100.00	—	(323.44)
	EBT	—	0	(1)	(4)	(7)	(6)	(11)	(12)	(6)	(6)
	EBT margin, %	—	(2,649.33)	(116.60)	(56.48)	(45.96)	(43.18)	(73.28)	(73.10)	0.00	(8,734.81)
	Net income	—	0	(1)	(4)	(7)	(6)	(11)	(18)	(9)	(9)
	Depreciation	—	—	0	1	2	2	2	2	0	0
Per share, $
Per share, $	Revenue	—	0.00	3.60	44.38	58.58	34.88	19.16	17.17	0.00	0.05
	Earnings	—	(0.05)	(4.20)	(25.07)	(25.22)	(13.51)	(12.57)	(19.52)	(8.47)	(5.76)
	Cash flow	—	(0.12)	(2.00)	(11.98)	(15.76)	(16.29)	(10.11)	(10.92)	(2.51)	(2.01)
	Capex	—	0.00	(2.17)	(10.46)	(4.08)	(1.00)	(0.89)	(0.28)	0.90	0.00
	Free cash flow	—	(0.12)	(4.17)	(22.44)	(19.84)	(17.29)	(11.00)	(11.20)	(1.61)	(2.01)
	Book value	—	0.10	0.79	(26.04)	30.74	21.23	23.91	4.94	(0.68)	(3.59)
	Shares, m	—	7	0	0	0	0	1	1	1	2
Valuation, ×
Valuation, ×	P/E	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—	0.00
	P/S	—	2.49	2.49	2.49	0.77	1.32	1.79	0.34	—	1.22
	P/B	—	0.00	0.00	0.00	1.46	2.16	1.43	1.17	—	0.00
	EV/Sales	—	2.58	2.58	2.58	0.89	1.27	1.31	0.30	—	0.98
	EV/FCF	—	(5.09)	(5.09)	(5.09)	(2.64)	(2.67)	(2.27)	(0.46)	—	(0.64)
Cash, $m
Cash, $m	Operating cash flow	—	(1)	0	(2)	(4)	(6)	(8)	(10)	(3)	(3)
	Capex	—	—	0	(2)	(1)	0	(1)	0	1	—
	Free cash flow	—	(1)	(1)	(3)	(5)	(6)	(8)	(11)	(2)	(3)
Balance, $m
Balance, $m	Working capital	—	2	0	(13)	(3)	(1)	4	4	(1)	(7)
	Total debt	—	1	1	1	2	2	0	2	—	—
	Net debt	—	(1)	0	1	2	(1)	(7)	(1)	0	(1)
	Shareholders’ equity	—	1	0	(4)	8	8	18	5	(1)	(6)
Returns, %
Returns, %	ROA	—	(26.44)	(3.97)	(49.44)	(41.26)	(27.60)	(44.88)	(95.60)	(156.21)	(891.19)
	ROIC	—	0.00	(99.09)	0.00	(39.37)	(56.77)	(57.54)	(190.28)	0.00	0.00
	ROE	—	(50.29)	(12.19)	162.40	(324.45)	(70.38)	(81.83)	(162.03)	(489.85)	381.10

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2024 · latest quarter Sep 2025

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
CANOQ Cano Health, Inc.	$6.6M	— (loss-making)	—	−21.05% (below 0%: shrinking)	n/m	−43.68% (below 0%: shrinking)	100.00%	(16.23%)	Compare
MODVQ ModivCare Inc.	$6.2M	— (loss-making)	— (loss-making)	−3.18% (below 0%: shrinking)	n/m	−3,767.70% (below 0%: shrinking)	14.06%	(1.78%)	Compare
BMGL Basel Medical Group Ltd	$6.2M	—	—	—	—	—	—	—	Compare
RHEP Adcare Health Systems Inc	$5.2M	0.6×	— (loss-making)	+143.03% (above 0%: growing)	n/m	+224.45% (above 0%: growing)	31.50%	(0.88%)	Compare
NIVF NewGenIvf Group Limited	$2.3M	—	—	—	—	—	—	—	Compare
SYRA Syra Health Corp.	$1.1M	84.0×	—	+23.03% (above 0%: growing)	n/m	−892.68% (below 0%: shrinking)	44.53%	10.51%	Compare
NVOS Novo Integrated Sciences, Inc.	$730.0K	— (loss-making)	— (loss-making)	−6.74% (below 0%: shrinking)	−43.27% (below 0%: shrinking)	−111.85% (below 0%: shrinking)	51.21%	(87.60%)	Compare
IONM Assure Holdings Corp.	$330.0K	— (loss-making)	— (loss-making)	−98.51% (below 0%: shrinking)	n/m	+95.63% (above 0%: growing)	(22,800.00%)	(138,800.00%)	Compare
BACK IMAC Holdings, Inc.	$150.0K	— (loss-making)	— (loss-making)	+34.18% (above 0%: growing)	n/m	−30.92% (below 0%: shrinking)	(484.43%)	(12,271.70%)
Median of peers	$3.8M	—	—	−4.96%	—	−77.77%	38.02%	(9.00%)

All 55 Medical Care Facilities stocks →